InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Monday, 07/15/2013 4:36:38 PM

Monday, July 15, 2013 4:36:38 PM

Post# of 26138
Finally, PR that promotes the company.

Biosante Pharmaceuticals Inc (NASDAQ:BPAX), declared enrollment of the first subject in the second legion of its worldwide Phase IIb clinical test to examine the safety and tolerability of Oxycyte® in patients with an acute, non-penetrating traumatic brain damage.



PR

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.